Products Categories
Basic Information
| CAS No.: | 11043-99-5 |
|---|---|
| Name: | Mitomalcin |
| Molecular Structure: | |
|
|
|
| Formula: | N/A |
| Molecular Weight: | 0 |
| Synonyms: | NSC 113233;NSC-B 2992 |
| Safety: | Poison by intraperitoneal, intravenous, subcutaneous, and intramuscular routes. |
| PSA: | 0.00000 |
| LogP: | 0.00000 |
Related products
- 144851-82-1METHYL2-AMINO-3-FLUOROBENZOATE
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 1219080-61-1IMIDAZOLE-2-BORONIC ACID
- Total:6 Page 1 of 1 1
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 11043-99-5
Mitomalcin
Toxicity Data With Reference
| 1. | ipr-mus LD50:2640 µg/kg NCICP* | |||
| 2. | scu-mus LD50:7053 µg/kg | NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 . | ||
| 3. | ivn-mus LD50:4952 µg/kg | NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 . | ||
| 4. | ims-mus LD50:7521 µg/kg | NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 . |
Safety Profile
Poison by intraperitoneal, intravenous, subcutaneous, and intramuscular routes.